Welcome to isctr.org
ISCTR at TCT: 2017 Symposium
Mark your calendar now for the ISCTR Tenth Annual Symposium Consensus Document on Clinical Endpoints/Surrogate and Magnitude of Improvement for Approval of Cardiovascular Devices to be held at TCT.17 on Sunday, October 29, 2017, from 8:00 a.m. to 5:30 p.m. in the Four Seasons Ballroom 4 at the Colorado Convention Center in Denver.
We are pleased to announce our keynote speaker will be Sir Magdi Yacoub, MD, FRS, FACC, who will discuss Ventricular Assist Devices: The Windy Road to Recovery and will be the 2017 recipient of the Glen and Marilyn Nelson Award for Innovation and Translation in Cardiovascular Research.
Dr. Yacoub, who serves on the ISCTR Governing Board as the London-based International Liaison, is Professor of Cardiothoracic Surgery at the National Heart and Lung Institute, Imperial College London, and Founder and Director of Research at the Harefield Heart Science Centre (Magdi Yacoub Institute), where he oversees more than 60 scientists and students in the areas of tissue engineering, myocardial regeneration, stem cell biology, end stage heart failure and transplant immunology. He is also Founder and Director of Magdi Yacoub Research Network which has created the Qatar Cardiovascular Research Center in collaboration with Qatar Foundation and Hamad Medical Corporation. He is the author of more than 1,000 articles. You can read more about Dr. Yacoub’s background and contributions to translational medicine here.
The agenda for the all-day meeting is being finalized and updates will be provided regularly on this site.
Update: Consensus Strategies for Device Development for Cardiovascular Disease
Building on our highly successful summit at the 2016 TCT meeting, ISCTR is collaborating with innovators, regulators, industry leaders, and others to create strategies and methodologies designed to achieve the rapid and cost-effective translation of cardiovascular device advances into clinical practice.
Working groups comprised of experts in their field have been formed to focus on specific areas of device development and implementation. The group dedicated to creating an overview of the translational pathway is being chaired by David R. Holmes, Jr., MD, MACC, while separate groups will concentrate on breaking down the methodologies involved in the development of aortic/pulmonic valves, led by Stanton Rowe; mitral/tricuspid valves, headed by Michael Mack, MD, FACC; stents, steered by Charles Simonton, MD, FACC; and catheter ablation devices, led by Douglas Packer, MD. These groups will be developing their sections throughout the summer and we expect to convene a meeting to review their critical efforts in August at the Food and Drug Administration.
Check back often to get more details about this meeting and the development of the documentation of these strategies as they are available. You can learn more about the genesis of this meeting through our coverage of our 2016 TCT summit here.
ESC Congress 2017
ISCTR President Nabil Dib, MD, MSc, FACC
will be presenting “The Optimal Process of Translating Basic Innovations into Clinical Care” during a session on Developments in Cardiovascular Translational Research that will also feature Eugene Braunwald, MD, MACC, MACP, and ISCTR Vice President Anthony DeMaria, MD, MACC.
View presentations from the 9th Annual ISCTR Symposium
Become an ISCTR Member
ISCTR’s member newsletter
International Society for
Cardiovascular Translational Research
The International Society for Cardiovascular Translational Research (ISCTR) is a non-profit organization that was founded in 2007 by Dr Nabil Dib with a goal to expedite scientific discovery to clinical application (patients).